BioSig enters $30M ATM equity deal with Cantor; issues 950k shares for services

Streamex Corp.

Enters ATM sales agreement with Cantor Fitzgerald to sell up to $30M of common stock.
Cantor will receive 3.0% commission on gross proceeds from share sales.
Issued 950,000 unregistered shares to service providers for business development.
Offering made under effective shelf registration statement (File No. 333-251859).

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Streamex Corp. entered into Controlled Equity Offering Sales Agreement with Cantor Fitzgerald & Co. (effective 2023-08-18).

Action: entry
Agreement: atm program
Counterparty: Cantor Fitzgerald & Co.
Effective: 2023-08-18

Exact text from the filing

On August 18, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Controlled Equity Offering SM Sales Agreement (the “Sales Agreement”) with Cantor Fitzgerald & Co., to act as the Company’s sales agent or principal (“Agent”), with respect to the issuance and sale of the Company’s shares of common stock

View on SEC.gov

Browse all material agreements →

Streamex Corp. filing history →

Source: SEC EDGAR

accession 0001185185-23-000873

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.